25 Nov

Proposed issue of securities - IVX

Proposed issue of securities Proposed issue of securities 1 / 6 Announcement Summary Entity name INVION LIMITED Announcement Type New announcement Date of this announcement 25/11/2021 The Proposed issue is: Total number of +securities proposed to be issued for a non pro rata offer of securities under a disclosure document or product disclosure statement (PDS) ASX +security code +Security description Maximum Number of +securities to be issued New class-code to be confirmed Listed Options exercisable at $0.04 expiring 18 months from date of issue 30000000 Closing date for receipt of acceptances 10/12/2021 Proposed +issue date 14/12/2021 Refer to next page for full details of the announcement A non pro rata offer of securities under a disclosure document or product disclosure statement (PDS) Proposed issue of securities Proposed issue of securities 2 / 6 Part 1 - Entity and announcement details 1.1 Name of +Entity INVION LIMITED We (the entity named above) give ASX the following information about a proposed issue of +securities and, if ASX agrees to +quote any of the +securities (including any rights) on a +deferred settlement basis, we agree to the matters set out in Appendix 3B of the ASX Listing Rules. If the +securities are being offered under a +disclosure document or +PDS and are intended to be quoted on ASX, we also apply for quotation of all of the +securities that may be issued under the +disclosure document or +PDS on the terms set out in Appendix 2A of the ASX Listing Rules (on the understanding that once the final number of +securities issued under the +disclosure document or +PDS is known, in accordance with Listing Rule 3.10.3C, we will complete and lodge with ASX an Appendix 2A online form notifying ASX of their issue and applying for their quotation). 1.2 Registered Number Type ABN Registration Number 76094730417 1.3 ASX issuer code IVX 1.4 The announcement is 1.5 Date of this announcement 25/11/2021 1.6 The Proposed issue is: A non-+pro rata offer of +securities under a +disclosure document or +PDS New announcement Proposed issue of securities Proposed issue of securities 3 / 6 Part 5 - Details of proposed non-pro rata offer under a disclosure document or PDS Part 5A - Conditions 5A.1 Do any external approvals need to be obtained or other conditions satisfied before the non-pro rata offer of +securities under a +disclosure document or + PDS can proceed on an unconditional basis? Part 5B - Offer details Is the proposed security a 'New class' (+securities in a class that is not yet quoted or recorded by ASX) or an 'Existing class' (additional securities in a class that is already quoted or recorded by ASX)? Will the proposed issue of this +security include an offer of attaching +securities? Details of +securities proposed to be issued ISIN Code (if Issuer is a foreign company and +securities are non CDIs) Have you received confirmation from ASX that the terms of the proposed +securities are appropriate and equitable under listing rule 6.1? Will the entity be seeking quotation of the 'new' class of +securities on ASX? ASX +security code New class-code to be confirmed +Security description Listed Options exercisable at $0.04 expiring 18 months from date of issue +Security type Options The number of +securities to be offered under the +disclosure document or +PDS 30,000,000 Will the offer be conditional on applications for a minimum number of +securities being received or a minimum amount being raised (i.e. a minimum subscription condition)? Will individual security holders be required to accept the offer for a No Yes No No New class No Proposed issue of securities Proposed issue of securities 4 / 6 Will individual security holders be required to accept the offer for a minimum number or value of +securities (i.e. a minimum acceptance condition)? Will individual security holders be limited to accepting the offer for a maximum number or value of +securities (i.e. a maximum acceptance condition)? Is the maximum acceptance unit based or dollar based? Please enter the maximum acceptance value 30,000,000 Offer price details Has the offer price been determined? How and when will the offer price be determined? Nil consideration for the acquisition of the options Will the offer price be determined by way of a bookbuild? Oversubscription & Scale back details Will the entity be entitled to accept over-subscriptions? Will a scale back be applied if the offer is over-subscribed? Will all the +securities issued in this class rank equally in all respects from their issue date? Options details +Security currency AUD - Australian Dollar Exercise price AUD 0.0400 Expiry date 14/6/2023 Details of the type of +security that will be issued if the option is exercised IVX : ORDINARY FULLY PAID Number of securities that will be issued if the option is exercised 30,000,000 fully paid ordinary shares Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities Yes No No No No Unit based Yes No Proposed issue of securities Proposed issue of securities 5 / 6 Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities proposed to be issued or provide the information by separate announcement. Part 5C - Timetable 5C.1 Lodgement date of +disclosure document or +PDS with ASIC 25/11/2021 5C.2 Date when +disclosure document or +PDS and acceptance forms will be made available to investors 30/11/2021 5C.3 Offer open date 30/11/2021 5C.4 Closing date for receipt of acceptances 10/12/2021 5C.6 Proposed +issue date 14/12/2021 Part 5D - Listing Rule requirements 5D.1 Has the entity obtained, or is it obtaining, +security holder approval for the entire issue under listing rule 7.1? 5D.1b Are any of the +securities proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 5D.1b ( i ) How many +securities are proposed to be issued without +security holder approval using the entity's 15% placement capacity under listing rule 7.1? 30,000,000 listed options 5D.1c Are any of the +securities proposed to be issued without +security holder approval using the entity's additional 10% placement capacity under listing rule 7.1A (if applicable)? 5D.2 Is a party referred to in listing rule 10.11 participating in the proposed issue? No No Yes No Proposed issue of securities Proposed issue of securities 6 / 6 Part 5E - Fees and expenses 5E.1 Will there be a lead manager or broker to the proposed offer? 5E.2 Is the proposed offer to be underwritten? 5E.3 Will brokers who lodge acceptances or renunciations on behalf of eligible +security holders be paid a handling fee or commission? 5E.4 Details of any other material fees or costs to be incurred by the entity in connection with the proposed offer Part 5F - Further Information 5F.01 The purpose(s) for which the entity intends to use the cash raised by the proposed issue Full details per the ASX announcement dated 16 November of funds include conditional agreements to 2021.Use co-develop Photosoft¿ technology for cancer & related diseases and exclusive distribution rights to the technology in Asia Pacific. 5F.1 Will the entity be changing its dividend/distribution policy if the proposed offer is successful? 5F.2 Please explain the entity's allocation policy for the offer, including whether or not acceptances from existing +security holders will be given priority Broker fee in relation to the Placement announced 16 November 2021. 30,000,000 options exercisable at 4 cents and expiring 18 months from date of issue. 5F.3 URL on the entity's website where investors can download the +disclosure document or +PDS asx-announcements www.inviongroup.com/ 5F.4 Any other information the entity wishes to provide about the proposed offer No No No No No No No
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Invion Limited (ASX:IVX) when you join Listcorp.